3 Myelofibrosis Clinical Trials in Birmingham, AL (2026)

Q: How do I join a clinical trial in Birmingham?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Birmingham research site will contact you.

Recruiting Myelofibrosis Studies in Birmingham

NCT06479135Recruiting

Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib

This clinical trial is evaluating whether addition of navtemadlin to ruxolitinib treatment will provide more clinical benefit than ruxolitinib alone for patients with Myelofibrosis who have a suboptim...

Birmingham, ALPHASE3600 participantsKartos Therapeutics, Inc.

View Study Details

NCT04176198Recruiting

A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis

This study is a Phase 1/2, multicenter, dose-escalation, open-label trial to assess safety, tolerability, pharmacokinetics and pharmacodynamics of nuvisertib (TP-3654) in patients with intermediate or...

Birmingham, ALPHASE1240 participantsSumitomo Pharma America, Inc.

View Study Details

NCT05280509Recruiting

Study of TL-895 Combined With Ruxolitinib in JAKi Treatment-Naïve MF Subjects and Subjects With MF Who Have a Suboptimal Response to Ruxolitinib

This study evaluates TL-895, a potent, orally-available and highly selective irreversible tyrosine kinase inhibitor for the treatment of Myelofibrosis. Participants must have MF (PMF, Post PV MF, or P...

Birmingham, ALPHASE170 participantsTelios Pharma, Inc.

View Study Details

About Myelofibrosis Clinical Trials in Birmingham

Myelofibrosis is a serious bone marrow disorder that disrupts normal blood cell production, leading to extensive scarring in the bone marrow. It can cause severe anemia, weakness, and an enlarged spleen. Treatment includes JAK inhibitors, blood transfusions, and stem cell transplant.

There are currently 3 myelofibrosis clinical trials recruiting participants in Birmingham, AL. These studies are seeking a combined 910 participants. Research is being sponsored by Kartos Therapeutics, Inc., Sumitomo Pharma America, Inc., Telios Pharma, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.

Myelofibrosis Clinical Trials in Birmingham — FAQ

Are there myelofibrosis clinical trials in Birmingham?

Yes, there are 3 myelofibrosis clinical trials currently recruiting in Birmingham, AL. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Birmingham?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Birmingham research site will contact you about next steps.

Are clinical trials in Birmingham free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Birmingham studies also compensate for your time and travel.

What myelofibrosis treatments are being tested?

The 3 active trials in Birmingham are testing new therapies including novel drugs, biologics, and treatment approaches for myelofibrosis.

Data updated August 28, 2026 from ClinicalTrials.gov